×
Learn about an FDA-approved treatment option. Download a Verzenio® savings card. Learn...
See Efficacy & Safety Data From A Pivotal Trial. View The PI & Boxed Warnings. ENHERTU Is Approved To Treat Eligible Patients.
See Full Prescribing Information, Including Boxed Warning. For Healthcare Providers. Read The Results Of The TRODELVY® Clinical Trial Design & Patient Response To Treatment. TRODELVY® Dosing Guide. Efficacy & Safety.
Understand How ENHERTU Works, Learn About An Approval. Read The PI & Boxed Warnings. View Clinical Study Results To See If ENHERTU May Be An Option For You Or A Loved One.

Sacituzumab govitecan

Drug
Sacituzumab govitecan, sold under the brand name Trodelvy by Gilead Sciences, is a Trop-2-directed antibody and topoisomerase inhibitor drug conjugate used for the treatment of metastatic triple-negative breast cancer and metastatic urothelial... Wikipedia
AHFS/Drugs.com: Monograph
ATC code: L01FX17 (WHO)
DrugBank: DB12893
Other names: IMMU-132, hRS7-SN-38, sacituzumab govitecan-hziy
PubChem CID: 91668186

Please See Important Facts, Including Important Warning. Learn More on the Patient Site. Ask Your Doctor if TRODELVY® May Fit...
View Testing Information For A 2L Treatment Option For Certain Patients With mBC. Visit The HCP Site For Medical...